pharma · Prurigo Nodularis · Vitiligo
Incyte
Incyte clinical programs — 10 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 1801 Augustine Cut-Off, Wilmington, Delaware 19803, US
- Employees
- 3,381
- Programs
- 53
- Drugs
- 61
- Patents
- 0
Incyte projects
10 ClinicalTrials.gov programs sponsored by Incyte.
Incyte has 10 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
INCA 33989-101
Incyte
Myeloproliferative Neoplasms
1 trial -
INCA33890
Incyte
Solid Tumors
1 trial -
INCB 123667-101
Incyte
Advanced or metastatic solid tumors
1 trial -
INCB 161734-101
Incyte
Advanced or metastatic solid tumors
1 trial -
INCB 57643-103
Incyte
Treatment of participants with MF, MDS, ET, or MDS/MPN
1 trial -
INCB 81776-101
Incyte
Advanced malignancies.
1 trial -
INCB 99280-205
Incyte
Solid tumor
1 trial -
INCB099280
Incyte
Advanced Solid Tumor
1 trial -
INCB160058-101
Incyte
Myeloproliferative Neoplasms
1 trial -
Itacitinib
Incyte
Acute Graft-versus-host Disease
1 trial
Frequently asked questions
How many clinical projects does Incyte have?
10 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.